Merck Kgaa
(MRK.D.DX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 2,760,500 | 2,834,800 | 2,841,000 | 2,852,100 | 2,645,000 |
| Cost of Goods | 860,300 | 1,393,400 | 787,600 | 807,800 | 748,700 |
| Gross Profit | 1,900,200 | 1,441,400 | 2,053,400 | 2,044,300 | 1,896,300 |
| Operating Expenses | 1,500,800 | 203,800 | 1,735,300 | 2,021,100 | 1,585,000 |
| Operating Income | 399,400 | 1,237,600 | 318,100 | 23,200 | 311,300 |
| Other Income | -58,700 | -986,600 | -58,100 | -69,700 | -65,200 |
| Pre-tax Income | 340,700 | 251,000 | 260,000 | -46,500 | 246,100 |
| Income Tax | 71,700 | -24,700 | 71,300 | 14,000 | 69,400 |
| Net Income Continuous | 269,000 | 275,700 | 188,700 | -63,200 | 174,200 |
| Minority Interests | -3,000 | -4,000 | -3,200 | 2,700 | 2,400 |
| Net Income | $266,000 | $271,800 | $185,500 | $-60,500 | $176,600 |
| EPS Basic Total Ops | 0.61 | 0.63 | 0.43 | -0.15 | 0.40 |
| EPS Basic Continuous Ops | 0.61 | 0.63 | 0.43 | -0.15 | 0.40 |
| EPS Diluted Total Ops | 0.61 | 0.63 | 0.43 | -0.15 | 0.40 |
| EPS Diluted Continuous Ops | 0.61 | 0.63 | 0.43 | -0.15 | 0.40 |
| EBITDA(a) | $753,800 | $717,900 | $660,900 | $375,100 | $654,000 |